CoChat

Efficacy of very low-calorie ketogenic diet with the Pronokal® method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial

Open access

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Abstract

Objective: The aim of this study isto assess the efficacy of a very low-calorie ketogenic diet (VLCKD) method vs a Mediterranean low-calorie diet (LCD) in obese polycystic ovary syndrome (PCOS) women of a reproductive age. Design: Randomized controlled open-label trial was performed in this study. The treatment period was 16 weeks; VLCKD for 8 weeks then LCD for 8 weeks, according to the Pronokal® method (experimental group; n = 15) vs Mediterranean LCD for 16 weeks (control group; n = 15). Ovulation monitoring was carried out at baseline and after 16 weeks, while a clinical exam, bioelectrical impedance analysis (BIA), anthropometry, and biochemical analyses were performed at baseline, at week 8, and at week 16. Results: BMI decreased significantly in both groups and to a major extent in the experimental group (−13.7% vs −5.1%, P = 0.0003). Significant differences between the experimental and the control groups were also observed in the reduction of waist circumference (−11.4% vs −2.9%), BIA-measured body fat (−24.0% vs −8.1%), and free testosterone (−30.4% vs −12.6%) after 16 weeks ( P = 0.0008, P = 0.0176, and P = 0.0009, respectively). Homeostatic model assessment for insulin resistance significantly decreased only in the experimental group ( P = 0.0238) but without significant differences with respect to the control group (−23% vs −13.2%, P > 0.05). At baseline, 38.5% of participants in the experimental group and 14.3% of participants in the control group had ovulation, which increased to 84.6% ( P = 0.031) and 35.7% ( P > 0.05) at the end of the study, respectively. Conclusion: In obese PCOS patients, 16 weeks of VLCKD protocol with the Pronokal® method was more effective than Mediterranean LCD in reducing total and visceral fat, and in ameliorating hyperandrogenism and ovulatory dysfunction. Significance statements: To the best of our knowledge, this is the first randomized controlled trial on the use of the VLCKD method in obese PCOS. It demonstrates the superiority of VLCKD with respect to Mediterranean LCD in reducing BMI with an almost selective reduction of fat mass and a unique effect of VLCKD in reducing visceral adiposity, insulin resistance, and in increasing SHBG with a consequent reduction of free testosterone. Interestingly, this study also demonstrates the superiority of the VLCKD protocol in improving ovulation, whose occurrence increased by 46.1% in the group treated by the VLCKD method against a rise of 21.4% in the group treated by Mediterranean LCD. This study extends the therapeutic approach possibilities in obese PCOS women.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/ec-22-0536

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow chart of the study. There were three drop-outs during the study, two in the experimental group, and one in the control group, all during the first 8 weeks of the study. The reasons for dropping out were kidney stones and gastrointestinal intolerance in the experimental group and scarce compliance with the diet in the control group.
Figure 1 Flow chart of the study. There were three drop-outs during the study, two in the experimental group, and one in the control group, all during the first 8 weeks of the study. The reasons for dropping out were kidney stones and gastrointestinal intolerance in the experimental group and scarce compliance with the diet in the control group.CC BY-NC-ND · PubMed Central
Figure 2 Total and free testosterone and SHBG at baseline (T0), 8 weeks (T1), and 16 weeks (T2) of the study in the experimental and control groups. Free testosterone was calculated by Vermeulen method. Data are expressed as mean and s.e.m.. *P = 0.0491 in the comparison between the two groups at baseline, and aP = 0.0234 and bP = 0.0036 in the comparison between T0 and T2 within the experimental group by ANOVA (no statistical differences were observed between T0 and T2 within the control group). P values shown in the figures represent the comparison between T0 and T1 and T1 and T2 within each group by ANOVA. The overall modification of free testosterone and SHBG during the study, estimated by the GLM, was significant only in the experimental group (P = 0.035 and P < 0.0001, respectively). Moreover, the overall modification of free testosterone and SHBG in the experimental group was significantly different with respect to the overall modification in the control group (P = 0.0009 and P = 0.0004, respectively).
Figure 2 Total and free testosterone and SHBG at baseline (T0), 8 weeks (T1), and 16 weeks (T2) of the study in the experimental and control groups. Free testosterone was calculated by Vermeulen method. Data are expressed as mean and s.e.m.. *P = 0.0491 in the comparison between the two groups at baseline, and aP = 0.0234 and bP = 0.0036 in the comparison between T0 and T2 within the experimental group by ANOVA (no statistical differences were observed between T0 and T2 within the control group). P values shown in the figures represent the comparison between T0 and T1 and T1 and T2 within each group by ANOVA. The overall modification of free testosterone and SHBG during the study, estimated by the GLM, was significant only in the experimental group (P = 0.035 and P < 0.0001, respectively). Moreover, the overall modification of free testosterone and SHBG in the experimental group was significantly different with respect to the overall modification in the control group (P = 0.0009 and P = 0.0004, respectively).CC BY-NC-ND · PubMed Central
Figure 3 Percentage of ovulation at baseline (T0) and 16 weeks (T2) of the study in the experimental and control groups. No statistical difference was observed between the two groups at baseline, but at the end of the study, it was significantly different between the two groups (P = 0.018) (χ2 test). *P = 0.031 by McNemar's test in the comparison between T0 and T2 within the experimental group. The comparison between T0 and T2 within the control group was not significant.
Figure 3 Percentage of ovulation at baseline (T0) and 16 weeks (T2) of the study in the experimental and control groups. No statistical difference was observed between the two groups at baseline, but at the end of the study, it was significantly different between the two groups (P = 0.018) (χ2 test). *P = 0.031 by McNemar's test in the comparison between T0 and T2 within the experimental group. The comparison between T0 and T2 within the control group was not significant.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 87 references

Cited by

See all 36

Metadata

Authors
Pandurevic, S., Mancini, I., Mitselman, D., Magagnoli, M., Teglia, R., Fazzeri, R., Dionese, P., Cecchetti, C., Caprio, M., Moretti, C., Sicinska, J., Agostini, A., Gazineo, D., Godino, L., Sajoux, I., Fanelli, F., Meriggiola, C. M., Pagotto, U., & Gambineri, A.
Affiliations
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
  • San Raffaele University of Rome (IT)
  • University of Rome Tor Vergata (IT)
  • Dermatology Clinic of CSK MSWiA Hospital, Warsaw, Poland
  • University of Bologna (IT)
  • Complejo Hospitalario Universitario de Santiago (ES)
  • Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Venue
Endocrine Connections
Published
2023-04-05
Volume
12
Issue
7
ISSN
2049-3614 (ISSN-L)
OpenAlex
W4362602529
Cited by
36
References
87
Citations by year
2026: 7 · 2025: 14 · 2024: 14 · 2023: 1
FWCI
8.63
Type
journal article
Language
en
Open access
Locations
  • Endocrine Connections (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
Keywords
very low-calorie ketogenic diet, polycystic ovary syndrome, obesity, weight loss, insulin resistance, hyperandrogenism, free testosterone, ovulation, fat loss, visceral fat, ovulatory dysfunction, women of reproductive age, bioelectrical impedance analysis, anthropometry, body mass index, waist circumference, HOMA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of very low-calorie ketogenic diet with the Pronokal® method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial. https://app.cochat.ai/papers/10.1530/ec-22-0536
The paper
Pandurevic, S., Mancini, I., Mitselman, D., Magagnoli, M., Teglia, R., Fazzeri, R., Dionese, P., Cecchetti, C., Caprio, M., Moretti, C., Sicinska, J., Agostini, A., Gazineo, D., Godino, L., Sajoux, I., Fanelli, F., Meriggiola, C. M., Pagotto, U., & Gambineri, A. (2023). Efficacy of very low-calorie ketogenic diet with the Pronokal® method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial. Endocrine Connections. https://doi.org/10.1530/ec-22-0536

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.